Research Publications

Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Creation of a large-scale genetic data bank for cardiovascular association studies.

Outcomes in African Americans and whites after percutaneous coronary intervention.

A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes.

Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injury.

Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial.

Nesiritide - not verified.

Aspirin resistance and its implications in clinical practice.

Molecular mechanisms of myocardial infarction.